Source link : https://www.newshealth.biz/health-news/til-therapy-may-offer-novel-approach-for-metastatic-lung-cancer/
Treatment with the autologous tumor-infiltrating lymphocyte (TIL) cell therapy lifileucel (Amtagvi) for pretreated metastatic non-small cell lung cancer was feasible, had a manageable safety profile, and induced responses, including in patients with profiles typically resistant to immunotherapy, according to findings from a small phase II trial. Findings from the study, IOV-COM-202, were presented at the […]
Author : News Health
Publish date : 2024-07-05 15:17:16
Copyright for syndicated content belongs to the linked Source.
Categories